Brazil invests R$42m in surveillance systems
This article was originally published in Clinica
Brazil's healthcare surveillance laboratories are to get almost R$42m (US$23.7m) this year to upgrade their facilities and to address new operational demands. The network of 27 central public health laboratories (Lacens) and the national healthcare quality controls institute (INCQS) are to receive, on the one hand, more than R$16.7m, to be shared among the laboratories for infrastructural and equipment improvements; on the other, R$25.1m will go to funding the network's operational costs in 2008.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.